Welcome to the UCSF Liver Center
The Liver Center is a consortium of 60 researchers who share a common interest in liver biology and disease. The goal of the Center is to integrate bench science with clinical investigation, in support of its vision to understand and cure human liver diseases.
The physicians and scientists of the Liver Center are committed to improving understanding of liver biology and alleviating suffering from liver diseases. Read More.
Jacquelyn Maher, MD
Program Director, Liver Center
Liver Center News
Annual Symposium Registration and Call for Abstracts
The Liver Center is now accepting registrations and abstract submissions.
Click here for more information.
2018 Pilot/Feasibility Grant Awardees
Dissecting the role of YAP and TAZ in hepatic stellate activation and liver fibrosis
The role of regulated IRE1 dependent decay (RIDD) in endoplasmic reticulum stress-induced liver cell death
An integrated analysis of the human gut metabolome and metagenome in nonalcoholic fatty liver disease
Upcoming National & International Conferences
EASL Annual Meeting 2019
April 10-14, 2019
Vienna, Austria
More Information
Digestive Diesease Week 2019
May 18-21, 2019
San Diego, CA
More Information
Featured Publications
Roberts DE, Kakar S, Mehta N, Gill RM. A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence. Am J Surg Pathol. 2018 Jul;42(7):855-865. doi: 10.1097/PAS.0000000000001053. PubMed
Schaub JR, Huppert KA, Kurial SNT, Hsu BY, Cast AE, Donnelly B, Karns RA, Chen F, Rezvani M, Luu HY, Mattis AN, Rougemont AL, Rosenthal P, Huppert SS, Willenbring H. De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation. Nature. 2018 May;557(7704):247-251. doi: 10.1038/s41586-018-0075-5. Epub 2018 May 2. PubMed
Perito ER, Roll G, Dodge JL, Rhee S, Roberts JP. Split liver transplantation and pediatric waitlist mortality in the United States: potential for improvement. Transplantation. 2018 Apr 21. doi: 10.1097/TP.0000000000002249. [Epub ahead of print] PubMed
Publicover J, Gaggar A, Jespersen JM, Halac U, Johnson AJ, Goodsell A, Avanesyan L, Nishimura SL, Holdorf M, Mansfield KG, Judge JB, Koshti A, Croft M, Wakil AE, Rosenthal P, Pai E, Cooper S, Baron JL. An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Sci Transl Med. 2018 Mar 21;10(433). pii: eaah5766. doi: 10.1126/scitranslmed.aah5766. PubMed